CORHIO awarded $1.7M

Friday, January 28, 2011

CORHIO, the Colorado Regional Health Information Organization, has been awarded $1.7 million by the Health Information Exchange (HIE) Challenge Grant Program run by the Office of the National Coordinator for Health IT (ONC). CORHIO was selected for innovation in the area of care improvement and cost reduction for patients transitioning between hospitals, long-term care facilities and other post-acute care providers. The Challenge Grant allows CORHIO to support long-term and post-acute care providers in Boulder, Colorado Springs, Pueblo and the San Luis Valley as they work to implement processes to improve care transitions to and from hospitals in their communities.  

2011 BioScience Day at the Capitol

Thursday, January 27, 2011

Media Advisory
Join us for the 3rd Annual BioScience Day at the Capitol BioBreakfast. Hear from our state legislators on their preview for the 2011 legislative session, learn about the CBSA's proposed legislation helping the bioscience industry, and listen as BIO describes the federal healthcare plan and other national issues impacting the industry. 

CBSA on Radio Colorado Network

Thursday, January 27, 2011

CBSA's President & CEO Holli Baumunk interviewed on the Radio Colorado Network's Business for Breakfast Show

CBSA President & CEO Holli Baumunk interviewed on the Radio Colorado Network's Business for Breakfast broadcast this morning, discussing the association's legislative initiatives and how the CBSA is accelerating life science growth in the state. She interviewed with Business For Breakfast Co-Host Woody Vincent.

KRCN-AM 1060 is the flagship station of the Radio Colorado Network (RNC). RCN is the only full-time "Business Talk" radio station serving the greater Denver, Fort Collins, and Cheyenne WY communities. The network is also found on KVLE-AM 610 Vail/Aspen, KWYD AM 1580 Colorado Springs-Pueblo and KSKE 1450 Buena Vista, plus online at


Link to listen to the Holli Baumunk interview

(approximately 10 minutes)

You can subscribe to the Business For Breakfast podcast rss feed at:




Continue Reading

Covidien delivers 20,000th ForceTriad

Wednesday, January 26, 2011

Covidien (Boulder) announced the delivery of the Company's 20,000th ForceTriad™ energy platform. The Dongzhimen Hospital, an affiliate of Beijing University of Chinese Medicine, in Beijing, China, took delivery of the device earlier this month. Known for its teaching and clinical research, Dongzhimen Hospital embraces both Chinese and Western medicine in serving the healthcare needs of its patients and the community. Since its launch in 2006, the ForceTriad platform has been placed into service in hospitals in 94 countries.  

Inviragen announces MOU

Wednesday, January 26, 2011

Inviragen, Inc. (Fort Collins) and the Duke-National University of Singapore Graduate Medical School ("Duke-NUS") announced today that they have completed a memorandum of understanding (MOU) to establish a partnership between the two organizations. The goal of the partnership is to better understand how emerging infectious diseases are transmitted and how transmission can be prevented. Through this collaborative program, Inviragen and Duke-NUS aim to advance the research and development of vaccines against infectious diseases such as dengue fever, hand, foot and mouth disease and chikungunya.

Weekly Legislative Report including SB11-047

Monday, January 24, 2011

CBSA's Policy Committee and Board have been working diligently on developing state policy priorities and working with our lobbyist, Erin Silver on creating two funding bills this upcoming session. The "Colorado Bioscience and Clean Technology Innovation Reinvestment Act," (SB11-047) sponsored by Senator Rollie Heath and Representatives Cheri Gerou and Jim Riesberg, would provide an additional funding stream for our Bioscience Discovery Evaluation Grant program (HB1001-08) that is due to sunset in 2012.    

FDA 510(k) Plan

Wednesday, January 19, 2011
The FDA's Center for Devices and Radiological Health (CDRH) released a report summarizing public comments related to initial recommendations released in August 2010, as well as a plan containing 25 actions for implementation in 2011 related to 510(k) approval.  (Full report)  Both AdvaMed and the MDMA released statements in response.
AdvaMed Statement   
Continue Reading

Allos Therapeutics publishes data

Wednesday, January 19, 2011

WESTMINSTER, Colo., Jan 19, 2011 (BUSINESS WIRE) -- Allos Therapeutics, Inc. (NASDAQ: ALTH) today announced that the Journal of Clinical Oncology has published data from the Company's pivotal Phase 2 PROPEL study demonstrating clinical activity of FOLOTYN® (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). These published results are from an updated analysis of the PROPEL study, which was the basis of the September 2009 U.S. Food and Drug Administration (FDA) accelerated approval of FOLOTYN - the only single-agent approved for the treatment of patients with relapsed or refractory PTCL. This indication is based on overall response rate. Clinical benefit such as improvement in progression-free survival or overall survival has not been demonstrated.  

Dwayne Romero named ED of OEDIT

Wednesday, January 19, 2011

DENVER — Gov. John Hickenlooper announced today Dwayne Romero will be Executive Director of the Office of Economic Development and International Trade. 

miRagen CU TTO Company of the Year

Tuesday, January 18, 2011

BOULDER, Colo., Jan 18, 2011 (BUSINESS WIRE) -- miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that it is the recipient of the University of Colorado (CU) Technology Transfer Office Bioscience Company of the Year award. The award will be conferred this evening at the CU Technology Transfer Annual Awards Banquet in Denver.